Evercore (EVR) Q2 2026 earnings review
Growth Normalizes Sequentially, but Underwriting Explodes
Evercore delivered a strong Q2 with Adjusted Net Revenues of $999.5M (+19% YoY) and Adjusted EPS of $2.91 (+20% YoY). While revenues decelerated sharply from Q1's anomalous $1.4B, this was entirely expected and guided by management. The core advisory business remains stable, but the standout was a massive 201% YoY surge in Underwriting fees to $97.1M. Operating leverage was a mixed bag: the adjusted compensation ratio improved to 63.5% (from 65.4% YoY), but this was offset by non-compensation costs rocketing 32% YoY. Overall, the structural story is intact, but margin expansion is being capped by aggressive cost inflation.
🐂 Bull Case
Underwriting activity is accelerating dramatically. A 201% YoY jump in Underwriting fees proves Evercore is successfully leveraging its advisory relationships to win highly lucrative bookrunner roles on major ECM deals.
The adjusted compensation ratio fell to 63.5% from 65.4% YoY. Evercore is demonstrating that it can absorb the costs of 188 Senior Managing Directors while still driving top-line growth that outpaces comp accruals.
🐻 Bear Case
Adjusted non-comp costs surged 32% YoY to $175.2M. Travel, tech investments, and professional fees are eating into the operating leverage generated by a lower comp ratio.
Advisory revenue fell sequentially from $1.24B in Q1 to $775.6M in Q2. While guided, this extreme volatility highlights the inherent risk of relying heavily on mega-cap transaction timing.
⚖️ Verdict: 🟢
Bullish. The expected sequential drop from an anomalous Q1 shouldn't mask the underlying strength. 19% YoY top-line growth, a booming underwriting segment, and a tightening comp ratio point to a highly functional operating model.
Key Themes
Underwriting Segment Explodes
Accelerating. Underwriting fees surged 201% YoY to $97.1M, up from $55.1M in Q1 and just $32.2M a year ago. Evercore acted as a bookrunner on 26 transactions this quarter (up 100% YoY), including massive roles like the left lead bookrunner on Red Cat's $259M follow-on and an active bookrunner on Parabilis Medicine's record-setting $771M biotech IPO. This illustrates a rapidly opening equity capital market.
Relentless Talent Acquisition
Stable. Evercore's primary growth engine—aggressively hiring Senior Managing Directors (SMDs)—continues. The firm ended Q2 with 188 IB SMDs, up from 159 a year ago. Four SMDs joined this quarter across Industrials, Private Capital, Private Capital Markets, and Healthcare. Seven more are committed. This built-in origination capacity ensures structural market share gains.
Wealth Management & Equities Diversification
Accelerating. The push to diversify away from pure M&A is working. Asset Management and Administration fees grew 15% YoY to $24.7M on an adjusted basis, supported by a 12% jump in AUM to $16.2B. Meanwhile, Commissions and Related Revenue grew 9% YoY to $63.5M on elevated trading volumes.
Runaway Non-Compensation Costs
Accelerating. Adjusted non-compensation costs rose 32% YoY to $175.2M. While management often points to technology investments and elevated travel, this pace vastly outstrips the 19% revenue growth. As a result, the adjusted non-comp ratio deteriorated to 17.5% from 15.9% a year ago, directly undercutting the 190 basis points of improvement seen in the compensation ratio.
Margin Compression Despite Narrative
Reversing. Management touted a 'record first half', but a look at sequential data contradicts the margin expansion story. Adjusted Operating Margin plunged to 19.0% in Q2 from 25.3% in Q1. While absolute YoY growth is positive, the firm's inability to hold the mid-20s margin profile due to lower advisory volume and higher overhead is a red flag for peak profitability.
Special Tax Charges Hit GAAP Earnings
Evercore booked a $21.3M special charge reflecting an estimated loss provision for non-U.S. employment taxes for prior periods. While excluded from adjusted earnings, this represents a meaningful actual cash/liability hit that warrants monitoring for any further international tax exposure as the firm expands its global footprint.
Macro: Large-Cap M&A Stabilizing
Stable. The macro backdrop for large strategic combinations remains highly constructive. Evercore pointed to major advisory roles closed in the quarter, such as Arcosa’s $8.5B sale to CRH and Iridium’s $8.0B sale to Rocket Lab. The environment is supportive, keeping baseline advisory fees healthy ($775.6M, +11% YoY).
Other KPIs
Decelerating favorably. The ratio dropped from 65.4% a year ago, showing that management can execute on top-line growth without handing all the incremental economics straight to the bankers. However, it still trails the highly efficient 62.0% posted in 25Q4.
Accelerating. Evercore aggressively repurchased 2.3 million shares at an average price of $324.60 during the first half. This heavy buyback activity completely neutralizes RSU dilution and reinforces management's confidence in the firm's cash generation.
Guidance
Stable. The dividend remains unchanged from the prior quarter, payable on September 11, 2026. This reflects a normalized baseline capital return policy.
Key Questions
Sustainability of Underwriting
Underwriting revenues just hit an incredible $97M, up 201% YoY. Given the historical volatility of ECM windows, how much of this quarter's performance do you view as a sustainable run-rate versus a temporary burst of pent-up IPO/follow-on demand?
Non-Compensation Cost Trajectory
Adjusted non-comp costs grew 32% YoY, vastly outpacing revenue growth and eroding operating leverage. What specific levers can management pull in the second half of 2026 to bring non-comp expense growth back in line with historical averages?
International Tax Exposure
You booked a $21.3M special charge for non-U.S. employment taxes. Should investors expect further true-ups in coming quarters as you finalize audits in your rapidly expanding EMEA footprint?
Robey Warshaw Integration Update
We are still seeing $7.1M in acquisition-related compensation charges this quarter. How is the pipeline synergy tracking in the UK/EMEA compared to your initial acquisition models, and when will these integration costs fully roll off?